Phase II trial of gemcitabine, carboplatin, and bevacizumab (Bev) in patients (pts) with advanced/metastatic urothelial carcinoma (UC) Meeting Abstract
| Authors: | Balar, A. V.; Milowsky, M. I.; Apolo, A. B.; Ostrovnaya, I.; Iasonos, A.; Trout, A.; Regazzi, A. M.; Garcia-Grossman, I. R.; Gallagher, D. J.; Bajorin, D. F. |
| Abstract Title: | Phase II trial of gemcitabine, carboplatin, and bevacizumab (Bev) in patients (pts) with advanced/metastatic urothelial carcinoma (UC) |
| Meeting Title: | 47th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 29 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2011 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2011-05-20 |
| Language: | English |
| ACCESSION: | WOS:000208880300607 |
| DOI: | 10.1200/jco.2011.29.15_suppl.4566 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4566 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
